[1] JONNA S, SUBRAMANIAM DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update[J].Discov Med,2019,27(148):167-170.
[2] AKAMINE T, TAKADA K, TOYOKAWA G,et al. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers[J].Surg Oncology-oxford,2018,27(1):88-94.
[3] ROSENBERG J E,DONNELL P H,BALAR A V, et al. Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy[J].J Clin Oncol,2019,37(29):2592-2600.
[4] 申刚磊, 胡孔法, 杨涛, 等. 基于复杂网络的名中医诊治肺癌用药规律分析[J].世界科学技术-中医药现代化, 2019, 21(3):501-505.
[5] ETTINGER D S, AISNER D L, WOOD D E, et al. NCCN guidelines insights: Non-Small Cell Lung Cancer, Version 5.2018[J].J Natl Compr Canc Netw,2018, 16(7):807-821.
[6] 李杰, 林洪生. 《中药新药治疗恶性肿瘤临床研究技术指导原则》修订过程及解析[J].中国新药杂志, 2016, 25(16):1833-1837.
[7] EISENHAUER E A,THERASSE P,BOGAERTS J,et al.New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).[J].Eur J Cancer,2009, 45(2):1-247.
[8] BOYD M R, PAULL K D. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen[J].Drug Development Res,2010,34(2):91-109.
[9] 于同月, 崔昊震, 张松男,等. 参一胶囊对晚期非小细胞肺癌临床化疗效果及免疫功能的影响分析[J].中国免疫学杂志, 2018, 34(7):1012-1016.
[10] QUISPEL-JANSSEN J,VAN DER NOORT V, DE VRIES J F, et al. Programmed Death 1 blockade with nivolumab in patients with recurrent malignant pleural mesothelioma[J].J Thorac Oncol,2018,13(10):1569-1576.
[11] 何伟. 基于关联规则及因子分析的现代中医药治疗肺癌组方配伍规律研究[J].中国中医基础医学杂志, 2018 ,24(9):1303-1305.
[12] 王子卿, 李燕, 王芬, 等. 二陈汤加沙参,麦冬对Lewis肺癌小鼠免疫功能及肿瘤血管生成的影响[J].中国中医药信息杂志, 2019, 026(008):40-45.
[13] KIM J H, SIM H A, JUNG D Y, et al. Poria cocus wolf extract ameliorates hepatic steatosis through regulation of lipid metabolism, inhibition of ER stress, and activation of autophagy via AMPK activation[J].Int J Mol Sci,2019, 20(19):4801.
[14] 李晓鲲, 荆丽丽, 姜人豪, 等. 枸杞多糖对恶性脑胶质瘤化疗效果影响的研究[J].中华肿瘤防治杂志, 2020, 27(18):1503-1507.
2022, Vol. 39 
